Skip to main content
STAR COMBO PHARMA LIMITED logo

STAR COMBO PHARMA LIMITED — Investor Relations & Filings

Ticker · S66 ISIN · AU0000004798 ASX Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2020-05-31 Director's Dealing
Country AU Australia
Listing ASX S66

About STAR COMBO PHARMA LIMITED

https://www.starcombo.com.au

Star Combo Pharma Limited specializes in the development, manufacturing, and distribution of vitamins, dietary supplements, and skincare products. The organization operates Therapeutic Goods Administration (TGA) licensed facilities, offering comprehensive Original Equipment Manufacturing (OEM) and Original Design Manufacturing (ODM) services. Its product portfolio encompasses a wide range of health and beauty solutions marketed under proprietary brands, including Costar, Living Healthy, Amax, and J&K. The company focuses on delivering premium health products to diverse markets, leveraging technical expertise in formulation and large-scale production. By maintaining rigorous quality control standards and providing end-to-end manufacturing solutions, the entity serves as a strategic partner for businesses seeking customized health and wellness products.

Recent filings

Filing Released Lang Actions
Initial Director's Interest Notice 2 pages 18.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with no securities held or contracts disclosed. This type of document is a report of personal share transactions or interests by company directors. It matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director interests, confirming it is not a broader financial or management report.
2020-05-31 English
Initial Director's Interest Notice 2 pages 18.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with no securities held or contracts disclosed. This type of document is a report of personal share transactions or interests by company directors. It matches the definition of 'Director's Dealing' filings, which report personal share transactions or interests by company directors and executives. The document length is short and focused solely on director interests, not financial results or other report types.
2020-05-31 English
Becoming a substantial holder 2 pages 927.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Goldenstar Pharmaceutical Investment Limited in Star Combo Pharma Limited, including voting power, relevant interests, registered holders, consideration paid, and addresses. This type of filing is a notification of a major shareholding change, specifically the initial substantial holder notice. It is not a financial report, audit, management report, or any other type of corporate filing listed. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2020-05-28 English
Cleansing Notice 1 page 163.1KB
Capital/Financing Update Classification · 95% confidence The document is a notification under section 708A(5)(e) of the Corporations Act 2001 regarding the issuance of shares under a private placement without disclosure to investors. It details the number of shares issued, the price, and compliance statements related to the Corporations Act. This is an announcement about a capital raising event and share issuance, not a full financial report or audit. The document length is short (1666 characters), and it is a formal notification to the ASX about a capital transaction. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-05-27 English
Star Combo Completes $33.3m Placement at $0.68 per share 2 pages 101.8KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 27 May 2020 from Star Combo Pharma Ltd regarding the successful completion of a A$33.3 million share placement to Goldenmax, a strategic partner. It details the use of proceeds, the strengthening of the balance sheet, and the appointment of two new directors from Goldenmax to the board. The document focuses on fundraising and capital structure changes, including share issuance and board appointments related to the placement. It does not contain financial statements or detailed financial performance data, nor is it a full report or transcript. The primary content is about capital raising and related board changes. Therefore, the document fits best under Capital/Financing Update (CAP) due to the share placement and capital raising focus, despite mentioning board appointments, which are secondary here. The document length is under 5,000 characters, but it is a substantive announcement, not just a brief notice or report publication announcement. Hence, CAP is the most appropriate classification.
2020-05-26 English
Star Combo Investor Update 15 pages 1.3MB
Investor Presentation Classification · 95% confidence The document is titled 'INVESTOR UPDATE PRESENTATION' and contains detailed information about the company's capital placement, strategic growth plans, manufacturing capabilities, revenue growth, and future investment plans. It includes financial figures, business strategy, and market positioning, which are typical contents of an investor presentation. There is no indication that this is a formal regulatory filing like an annual or interim report, nor is it a brief announcement or certification. The length and content suggest it is a comprehensive presentation aimed at investors, focusing on financials, strategy, and market position. Therefore, the document fits best under the category 'Investor Presentation' (IP).
2020-05-26 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.